Form 4: Anika Therapeutics CEO Cheryl Blanchard Reports Stock Transactions
SEC Form 4 Filing
Cheryl Blanchard, CEO of Anika Therapeutics, reports the vesting of RSUs, tax withholding, and a transfer of shares to a revocable trust.
Summary
- Cheryl Blanchard, the President, CEO, and Director of Anika Therapeutics, reported transactions involving Anika Therapeutics common stock.
- On March 10, 2025, 20,002 Restricted Stock Units (RSUs) vested, representing the second vesting installment of RSUs granted on March 9, 2023.
- 5,871 shares were withheld by the issuer to satisfy tax obligations related to the RSU vesting at a price of $16.62 per share.
- Blanchard transferred 11,742 shares to The Cheryl R. Blanchard Amended and Restated Revocable Trust dated December 19, 2014.
- Following these transactions, Blanchard directly owns 166,955 shares and indirectly owns 11,742 shares through the trust, and holds 20,001 derivative securities.
Sentiment
Score: 5
Explanation: This is a standard regulatory filing reflecting routine stock transactions. It doesn't inherently indicate positive or negative sentiment.
Industry Context
This Form 4 filing is a routine disclosure related to executive compensation and stock ownership, common in publicly traded companies. It provides transparency to investors regarding insider transactions.
Comparison to Industry Standards
- Executive compensation packages often include stock options and restricted stock units (RSUs) to align management's interests with those of shareholders.
- Vesting schedules for RSUs typically span several years to incentivize long-term performance.
- Tax withholding on vested RSUs is a standard practice.
- Executives commonly use revocable trusts for estate planning purposes.
Stakeholder Impact
- The transactions provide transparency to shareholders regarding executive stock ownership.
- The tax withholding impacts the company's cash flow.
Key Dates
| Date | Description |
|---|---|
| December 19, 2014 | Date of The Cheryl R. Blanchard Amended and Restated Revocable Trust |
| March 9, 2023 | Date of RSU grant |
| March 9, 2024 | First vesting date of RSUs |
| May 14, 2024 | Purchase of 800 shares under Employee Stock Purchase Plan |
| November 14, 2024 | Purchase of 330 shares under Employee Stock Purchase Plan |
| March 7, 2025 | Trading day prior to RSU vesting, ANIK closing price used for tax withholding valuation |
| March 10, 2025 | Date of RSU vesting and stock transactions |
| March 11, 2025 | Date of Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.